Finding new therapeutics to counter the progression of Dry AMD and prevent the geographical atrophy has never been more important. The aging population creates an ever-growing clinical need for next-generation therapeutics.

This action-packed two-day digital agenda holds 22 Presentations from industry and academic leaders, a virtual poster session and 5+ hours of networking, you can join the only platform discussing issues present in the development of Dry AMD therapeutics.

Join this critical global forum which will be uniting industry specialists from pharma, biotechs, academia and solution providers as we target the most pressing issues important to bringing the next generation of Dry AMD drugs to market.

Companies speaking include: Genentech, 4D Molecular Therapeutics, Alkeus Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, University of California, San Francisco, Regenerative Patch Technologies, Novartis, Stealth BioTherapeutics Inc

Find out more here > https://ter.li/mc1pmz